Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances
- PMID: 28127947
- PMCID: PMC6069525
- DOI: 10.1002/ieam.1885
Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substances
Abstract
A SETAC Pellston Workshop® "Environmental Hazard and Risk Assessment Approaches for Endocrine-Active Substances (EHRA)" was held in February 2016 in Pensacola, Florida, USA. The primary objective of the workshop was to provide advice, based on current scientific understanding, to regulators and policy makers; the aim being to make considered, informed decisions on whether to select an ecotoxicological hazard- or a risk-based approach for regulating a given endocrine-disrupting substance (EDS) under review. The workshop additionally considered recent developments in the identification of EDS. Case studies were undertaken on 6 endocrine-active substances (EAS-not necessarily proven EDS, but substances known to interact directly with the endocrine system) that are representative of a range of perturbations of the endocrine system and considered to be data rich in relevant information at multiple biological levels of organization for 1 or more ecologically relevant taxa. The substances selected were 17α-ethinylestradiol, perchlorate, propiconazole, 17β-trenbolone, tributyltin, and vinclozolin. The 6 case studies were not comprehensive safety evaluations but provided foundations for clarifying key issues and procedures that should be considered when assessing the ecotoxicological hazards and risks of EAS and EDS. The workshop also highlighted areas of scientific uncertainty, and made specific recommendations for research and methods-development to resolve some of the identified issues. The present paper provides broad guidance for scientists in regulatory authorities, industry, and academia on issues likely to arise during the ecotoxicological hazard and risk assessment of EAS and EDS. The primary conclusion of this paper, and of the SETAC Pellston Workshop on which it is based, is that if data on environmental exposure, effects on sensitive species and life-stages, delayed effects, and effects at low concentrations are robust, initiating environmental risk assessment of EDS is scientifically sound and sufficiently reliable and protective of the environment. In the absence of such data, assessment on the basis of hazard is scientifically justified until such time as relevant new information is available. Integr Environ Assess Manag 2017;13:267-279. © 2017 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Keywords: Ecotoxicological hazard assessment; Ecotoxicological risk assessment; Endocrine disruptors.
© 2017 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Figures

Similar articles
-
Ecotoxicological hazard and risk assessment of endocrine active substances.Integr Environ Assess Manag. 2017 Mar;13(2):264-266. doi: 10.1002/ieam.1868. Epub 2017 Jan 18. Integr Environ Assess Manag. 2017. PMID: 27862919
-
Population-relevant endpoints in the evaluation of endocrine-active substances (EAS) for ecotoxicological hazard and risk assessment.Integr Environ Assess Manag. 2017 Mar;13(2):317-330. doi: 10.1002/ieam.1887. Integr Environ Assess Manag. 2017. PMID: 28052490
-
Uncertainties in biological responses that influence hazard and risk approaches to the regulation of endocrine active substances.Integr Environ Assess Manag. 2017 Mar;13(2):293-301. doi: 10.1002/ieam.1866. Epub 2017 Jan 18. Integr Environ Assess Manag. 2017. PMID: 27862884 Free PMC article.
-
Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer?Endocr Metab Immune Disord Drug Targets. 2020;20(10):1664-1681. doi: 10.2174/1871530320666200606225104. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32504507 Review.
-
Evaluating the credibility of histopathology data in environmental endocrine toxicity studies.Environ Toxicol Chem. 2017 Mar;36(3):601-611. doi: 10.1002/etc.3695. Epub 2017 Jan 10. Environ Toxicol Chem. 2017. PMID: 27883231 Review.
Cited by
-
AOP Report: Adverse Outcome Pathways for Aromatase Inhibition or Androgen Receptor Agonism Leading to Male-Biased Sex Ratio and Population Decline in Fish.Environ Toxicol Chem. 2023 Apr;42(4):747-756. doi: 10.1002/etc.5581. Epub 2023 Mar 14. Environ Toxicol Chem. 2023. PMID: 36848318 Free PMC article.
-
Toward an AOP Network-Based Tiered Testing Strategy for the Assessment of Thyroid Hormone Disruption.Environ Sci Technol. 2020 Jul 21;54(14):8491-8499. doi: 10.1021/acs.est.9b07205. Epub 2020 Jul 9. Environ Sci Technol. 2020. PMID: 32584560 Free PMC article.
-
A Multidimensional Matrix Model for Predicting the Effects of Male-Biased Sex Ratios on Fish Populations.Environ Toxicol Chem. 2022 Apr;41(4):1066-1077. doi: 10.1002/etc.5287. Epub 2022 Feb 16. Environ Toxicol Chem. 2022. PMID: 35020961 Free PMC article.
-
Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour - Results of a retail survey in the UK and Germany - 3. Pesticide residue content.Food Chem X. 2020 Mar 29;7:100089. doi: 10.1016/j.fochx.2020.100089. eCollection 2020 Sep 30. Food Chem X. 2020. PMID: 32637911 Free PMC article.
-
Establishing the relevance of endocrine-disrupting effects for nontarget vertebrate populations.Integr Environ Assess Manag. 2019 Mar;15(2):299-300. doi: 10.1002/ieam.4116. Integr Environ Assess Manag. 2019. PMID: 30806497 Free PMC article. No abstract available.
References
-
- Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741. - PubMed
-
- Ankley GT, Gray LE. 2013. Cross-species conservation of endocrine pathways: A critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ Toxicol Chem 32:1084–1087. - PubMed
-
- Ankley GT, LaLone CA, Gray LE, Villeneuve DL, Hornung MW. 2016. Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems. Environ Toxicol Chem 35(11):2806–2816. - PubMed
-
- Ankley GT, Villeneuve DL. 2015. Temporal changes in biological responses and uncertainty in assessing risks of endocrine-disrupting chemicals: Insights from intensive time-course studies with fish. Toxicol Sci 144: 259–275. - PubMed
-
- Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol 72:514–537. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources